Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 1, 2022
Reporting Period: Fiscal fourth quarter and full year ended December 31, 2021.
This filing serves to announce the release of financial results for the specified period via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references a press release containing the actual financial data but does not include the specific figures within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only confirms that results for the fourth quarter and full year 2021 were announced.
Guidance, Outlook, and Risks
Management Commentary: The filing states that results were announced via press release. The text explicitly notes that the information in the attached press release is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, limiting liability.
Guidance and Risks: No specific guidance, outlook, risk factors, contingencies, or unusual items are detailed in the provided text.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for actual revenue, net income, and cash flow figures for Q4 and FY 2021.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any forward-looking statements or updated guidance included in the press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial report.